Xintian Pharmaceutical (002873.SZ): Net profit of 15.571,600 yuan in the first quarter decreased by 37.94% year-on-year

Gelonghui, April 26 | Xintian Pharmaceutical (002873.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 177 million yuan, down 15.06% year on year; net profit attributable to shareholders of listed companies was 15.571,600 yuan, down 37.94% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 147.152 million yuan, down 38.53% year on year; basic earnings per share were 0.0673 yuan.

Gelonghui FinanceApr 26 06:12 ET

Guiyang Xintian PharmaceuticalLtd (SZSE:002873) Sheds 14% This Week, as Yearly Returns Fall More in Line With Earnings Growth

It might be of some concern to shareholders to see the Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) share price down 22% in the last month. But that doesn't change the fact that the return

Simply Wall StApr 18 22:33 ET

Xintian Pharmaceutical (002873.SZ): Strategically invested in Huilun Pharmaceutical, the current shareholding ratio is 14.88%

Gelonghui, April 17 | Xintian Pharmaceutical (002873.SZ) said on the investor interactive platform that the company's strategic investment in Huilun Pharmaceutical currently has a shareholding ratio of 14.88%. According to relevant accounting policy regulations, it has not yet been included in the scope of the company's consolidated statements, and changes in its operating performance will not have a significant impact on the company's 2023 net profit and other indicators. According to a thorough understanding of the business situation of Huilun Pharmaceutical Company, it is a high-tech enterprise dedicated to R&D and technical services for small molecule innovative drugs and generic drugs. The industrialization and commercialization process of its chemical products has been steady, and its business has grown rapidly in the past three years. 2

Gelonghui FinanceApr 17 04:29 ET

Xintian Pharmaceutical (002873.SZ) announced its 2023 annual results, net profit of 808.711 million yuan, a decrease of 27.48%

Xintian Pharmaceutical (002873.SZ) released its 2023 annual report. During the reporting period, the company achieved an operating income of 9...

Zhitong FinanceApr 11 08:17 ET

Xintian Pharmaceutical (002873.SZ): As of April 10, 2024, the number of shareholders in the company was 18,837

Gelonghui, April 11 | Xintian Pharmaceutical (002873.SZ) said on an interactive platform that as of April 10, 2024, the number of shareholders of the company was 18,837.

Gelonghui FinanceApr 11 05:34 ET

Xintian Pharmaceutical (002873.SZ) has spent 75.3 million yuan to buy back 8.806 million shares

Xintian Pharmaceutical (002873.SZ) issued an announcement. As of March 31, 2024, the company has approved share repurchases...

Zhitong FinanceApr 1 07:57 ET